In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cellzome GMBH gets $31mm in second round

Executive Summary

German functional proteomics start-up Cellzome GMBH has completed a second-round $31mm (Euro34mm) private placement to returning investors Atlas Venture, Advent International and Heidelberg Innovation, joined by new participants Index Ventures (which led the round), Sofinnova, and Schroders Investment Management. Index general partner Neil Rimer will also join Cellzome's board.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies